Riskpilot← Back to searchSign inGet full accessSundhedshus Gråsten ApS
APSActiveCVR 39251701Egernvej 6Buying and selling of own real estate · NACE 6811Est. 2018— employees
Revenue 2025
DKK 891K
-1% vs 2024
EBITDA margin
100.0%
-1% vs 2024
Equity ratio
6.2%
Financial strength
Net profit 2025
DKK 179K
+96% vs 2024
| Revenue | DKK 891K | -1% |
| EBITDA | DKK 891K | -1% |
| Net profit | DKK 179K | +96% |
| Total assets | DKK 16,6M | -2% |
| Equity | DKK 1M | +21% |
| Employees | — | — |
Legal name
Sundhedshus Gråsten ApS
CVR number
39251701
Legal form
Anpartsselskab
NACE code
6811 · Buying and selling of own real estate
Founded
11. januar 2018
Share capital
DKK 100.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse.
Company purpose
Selskabets formål er primært at erhverve ejerlejlighed nr. 2, 4 og 5 i ejendommen matr.nr. 0811 og 1307 Gråsten, Gråsten-Adsbøl, samt drive udlejningsvirksomhed med relation til nævnte ejerlejligheder samt sekundært køb og salg af ejendomme, udlejning samt dermed beslægtet virksomhed.
Address
Egernvej 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 735 | 756 | 820 | 898 | 891 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 735 | 756 | 820 | 898 | 891 |
| Depreciation & amort. | -123 | -123 | -123 | -123 | -123 |
| EBIT | 612 | 633 | 697 | 775 | 768 |
| Net financials | -289 | -323 | -605 | -623 | -504 |
| Profit before tax | 323 | 310 | 91 | 152 | 264 |
| Tax | 71 | 176 | 47 | 60 | 85 |
| Net profit | 252 | 133 | 44 | 91 | 179 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 17.183 | 16.905 | 16.842 | 16.953 | 16.610 |
| Equity | 586 | 719 | 763 | 855 | 1.034 |
| Long-term debt | 15.592 | 15.217 | 15.261 | 15.066 | 14.548 |
| Short-term debt | 1.005 | 969 | 818 | 1.032 | 1.029 |
| Total debt | 16.597 | 16.186 | 16.079 | 16.098 | 15.577 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20212025
Equity ratio
6.2%
This company
38.2%
Market median
-84% vs market
20212025
Return on equity
17.3%
This company
18.4%
Market median
+6% vs market
20212025
Net profit margin
20.1%
This company
8.1%
Market median
+148% vs market
20212025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
15.07×
This company
0.62×
Market median
-2331% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BR Management | Management | 2019 |
| Former (1) | ||
EL Management | Management | 2018 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2018 | |
| Chairman | 2018 | |
| Board of Directors | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2018 | |
| Company | 20–24.99% | 20–24.99% | 2018 | |
| Company | 20–24.99% | 20–24.99% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BRA INVEST ApS
Sundhedshus Gråsten ApS Board members of Sundhedshus Gråsten ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bent Rasmussen | Management | 0 companies |
| Erling Lausen | Management | 0 companies |
| Henning Valdemar Kjær | Board of Directors | 0 companies |
| Birgitte Schøning | Chairman | 0 companies |
| Jesper Thomsen | Board of Directors | 0 companies |